August 14, 2020 ePRO Consortium Announces Publication of Open Access Article C-Path’s ePRO Consortium is pleased to announce that “Demystifying Submissions of eCOA Documentation for Ethics
August 11, 2020 Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes , September 2019
July 30, 2020 C-Path Partners with CHDR to Expand Global Collaborations The Critical Path Institute and the Centre for Human Drug Research (CHDR) have joined forces to expand global collaborations for b
July 22, 2020 C-Path’s PSTC, D-RSC Receive Positive FDA Response for Drug-Induced Skeletal Muscle Injury Biomarkers Safety biomarkers aim to provide an additional tool for detecting acute drug-induced skeletal muscle injury in phase 1 clinical tr
July 21, 2020 C-Path’s PSTC, D-RSC Receive Positive FDA Response to Plan for Liver Safety Biomarker Biomarker aims to provide an additional tool for detecting the onset of hepatic injury in clinical trials involving patients with
July 14, 2020 C-Path Data Collaboration Center Analytics Team Wins Metadata Automation DREAM Challenge TUCSON, Ariz., July 14, 2020 — Tucson-based Critical Path Institute (C-Path) today proudly announced that the analytics team f
June 24, 2020 Watch now: Shortening the Timeline for Developing New Treatments – How the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) Can Help Webinar Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelera
